The Elevator, “The Magazine for a Wealth of Opportunity”, December 2007
This post is about the integral and unavoidable aspect of project development – seeking development capital. The title could conceivably read “From Switzerland With Love”, if a play on words were intended. Such as the name of The Elevator magazine is a reference to the phrase “elevator pitch”, a standard concept in the venture capital/private equity arena (meaning a very brief introductory pitch of the investment proposition; The Elevator articles are naturally somewhat more extensive than that).
The editor of The Elevator reviewed and published bioZhena after we responded to their invitation, “Seeking Deals to Fund”, http://www.linkedin.com/pub/0/456/786 .
The Elevator (“The Magazine for a Wealth of Opportunity”) is an impressively produced electronic magazine, attached. On page 3, the editor writes: “…since our first issue in March 2006 we have reviewed over 300 projects and retained 60 of them as features. More than 10,000 individuals have seen The €levator ; we’ve had a great diversity of projects, much interest and several deals closed over the past 12 months. … I invite all our readers to become active members of our investor’s forum …“.
On page 35 appears the following claim: OUR TEAM OF EXPERTS PROVIDES ACCESS TO THE BEST SOLUTIONS IN PRIVATE EQUITY, ASSET MANAGEMENT AND VIP ADVISORY.
Here are the headlines from the magazine’s title page, featuring a partial list of contents, and bioZhena is one of these featured listings:
- How to open your own fund. An introduction by the experts of JP Fund Services
- bioZhena. The turnkey technology for birth control
- VentureLab. The professional matching platform
- The Village Barbados. Prime Luxury Retreat seeking USD 31 million
The interesting thing about this presentation of bioZhena, by the Geneva-area international business VC/PE deal-maker, is their risk scale. We see a scale with 6 colors, from green and light green, through yellow, then light pink and dark pink, and finally the highest risk level is red.
The editor indicates the risk level of the bioZhena proposition as between light green and yellow (or level 4 on a scale of 1 to 11). This is the same as that of the real estate deal “The Village Barbados”, and it is better than the level 5 [yellow] risk level of the VentureLab deal, and it compares favorably with the various other listings in this December issue of the Elevator. Only the Yacht Club Mediterranean and the Castellan, New York real estate deals are assessed with lower risk levels, 2 and 1 respectively.
It is also interesting that bioZhena’s risk level is assessed the same as that of DealFlow, Toronto – “a television series that captures the drama and sport of global business as seen through the eayes of dealmakers”. DealFlow “is currently seeking US$620,000 in a US$875,000 Private Placement Offering of Convertible Preferred shares at US$20.00 per share”.
bioZhena’s investment opportunity is described as follows:
Investment Volume: Up to $ 15 Million (current Offering for $3M plus 1-year $3M Warrant)
Est. Return on Investment: 100%+
Est. Duration: Approx. 3 Years
Minimum Investment: $250,000 or a portion thereof at Company’s discretion
Ref.:
The Elevator, “The Magazine for a Wealth of Opportunity”, December 2007
bioZhena's Weblog 